7.5 tirzepatide to semaglutide vs Semaglutide: SURMOUNT-5 Results Flavor:Peach Mango Eli Lilly will allow Zone 7a

7.5 tirzepatide to semaglutide vs Semaglutide: SURMOUNT-5 Results Flavor:Peach Mango Eli Lilly will allow Zone 7a

Eli Lilly will allow a limited number of patients early access to retatrutide, its next-generation weight loss drug, before it gets FDA approval. MORE BELOW⬇️

“In our study, hair loss was uncommon overall, but it was a real signal and should not be brushed aside.” It’s important to point this out: The study was observational, so it can’t prove that taking tirzepatide or semaglutide caused the hair loss

Zone 7a

Flavor:Peach Mango

18 Additional Warnings and Precautions Although not studied in humans, tirzepatide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as it was found to develop tumors in rats